Technical Analysis for LEGN - Legend Biotech Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 28.45 | -6.14% | -1.86 |
LEGN closed down 6.14 percent on Friday, April 9, 2021, on 82 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Down |
| Historical LEGN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| Stochastic Sell Signal | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Slingshot Bullish | Bullish Swing Setup | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Crossed Above 200 DMA | Bullish | -6.14% | |
| Doji - Bearish? | Reversal | -6.14% | |
| Multiple of Ten Bullish | Other | -6.14% | |
| Outside Day | Range Expansion | -6.14% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 5% | 1 day ago |
| Fell Below 10 DMA | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 1 ATR | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Legend Biotech Corporation develops cell therapy solutions for cancer patients. The company was founded in 2014 and is based in Cayman Islands. The company operates as a subsidiary of Genscript Biotech Corporation.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Cell Therapy Corporate Tax Avoidance Spotlight Innovation Tax Investigation Genscript Biotech
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Cell Therapy Corporate Tax Avoidance Spotlight Innovation Tax Investigation Genscript Biotech
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 43.2399 |
| 52 Week Low | 23.41 |
| Average Volume | 371,306 |
| 200-Day Moving Average | 30.21 |
| 50-Day Moving Average | 26.97 |
| 20-Day Moving Average | 28.00 |
| 10-Day Moving Average | 29.05 |
| Average True Range | 1.44 |
| ADX | 21.44 |
| +DI | 20.83 |
| -DI | 16.38 |
| Chandelier Exit (Long, 3 ATRs ) | 26.06 |
| Chandelier Exit (Short, 3 ATRs ) | 27.90 |
| Upper Bollinger Band | 30.71 |
| Lower Bollinger Band | 25.29 |
| Percent B (%b) | 0.58 |
| BandWidth | 19.34 |
| MACD Line | 0.81 |
| MACD Signal Line | 0.64 |
| MACD Histogram | 0.1659 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 31.50 | ||||
| Resistance 3 (R3) | 31.78 | 31.04 | 30.99 | ||
| Resistance 2 (R2) | 31.04 | 30.26 | 30.90 | 30.82 | |
| Resistance 1 (R1) | 29.75 | 29.78 | 29.38 | 29.47 | 30.65 |
| Pivot Point | 29.01 | 29.01 | 28.82 | 28.87 | 29.01 |
| Support 1 (S1) | 27.71 | 28.23 | 27.34 | 27.43 | 26.25 |
| Support 2 (S2) | 26.97 | 27.75 | 26.83 | 26.08 | |
| Support 3 (S3) | 25.68 | 26.97 | 25.91 | ||
| Support 4 (S4) | 25.40 |
